Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [12622]

FDA approves retifanlimab-dlwr with carboplatin and paclitaxel and as a single agent for squamous cell carcinoma of the anal canal

FDA approves retifanlimab-dlwr with carboplatin and paclitaxel and as a single agent for squamous cell carcinoma...

Daratumumab may help cancer patients with low physical function to live longer, study finds

Daratumumab may help cancer patients with low physical function to live longer, study finds

Reimagining cancer therapy by targeting the MYC axis

Reimagining cancer therapy by targeting the MYC axis

Novel blood-based biomarker analysis provides insights to improve therapy decisions and treatment outcomes for patients with metastatic disease

Novel blood-based biomarker analysis provides insights to improve therapy decisions and treatment outcomes for...

Study advances understanding of personalised vaccines for bladder cancer

Study advances understanding of personalised vaccines for bladder cancer

Liver cancer survival rates reflect income disparities

Liver cancer survival rates reflect income disparities

Diabetes drug as a possible treatment for prostate cancer

Diabetes drug as a possible treatment for prostate cancer

Incidence rates of some cancer types have risen in people under age 50

Incidence rates of some cancer types have risen in people under age 50

Targeting epigenetics: new insights into oral cancer progression and treatment

Targeting epigenetics: new insights into oral cancer progression and treatment

Exercise can counter detrimental effects of cancer treatment

Exercise can counter detrimental effects of cancer treatment

More from ecancer